Tandem Diabetes Care Inc [TNDM] stock prices are up 2.87% to $45.57 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TNDM shares have gain 8.68% over the last week, with a monthly amount glided 22.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on August 22, 2024, when Morgan Stanley initiated its Equal-Weight rating and assigned the stock a price target of $45. Previously, Canaccord Genuity started tracking the stock with Buy rating on August 08, 2024, and set its price target to $57. On May 30, 2024, Redburn Atlantic initiated with a Buy rating and assigned a price target of $60 on the stock. Citigroup upgraded its rating to a Buy and increased its price target to $57 on May 22, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $45 on April 29, 2024. Leerink Partners upgraded its rating to Outperform for this stock on April 25, 2024, and upped its price target to $45. In a note dated March 26, 2024, Stifel upgraded an Buy rating on this stock and boosted its target price from $24 to $37.
The stock price of Tandem Diabetes Care Inc [TNDM] has been fluctuating between $13.82 and $53.69 over the past year. Currently, Wall Street analysts expect the stock to reach $84.44 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $45.57 at the most recent close of the market. An investor can expect a potential return of 85.3% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
The Tandem Diabetes Care Inc [NASDAQ:TNDM] reported sales of 796.00M for trailing twelve months, representing a surge of 13.27%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -0.17%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.49 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.23 points at the first support level, and at 42.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.53, and for the 2nd resistance point, it is at 47.48.
Ratios To Look Out For
It’s worth pointing out that Tandem Diabetes Care Inc [NASDAQ:TNDM]’s Current Ratio is 3.05. As well, the Quick Ratio is 2.38, while the Cash Ratio is 0.2. Considering the valuation of this stock, the price to sales ratio is 3.75, the price to book ratio is 12.75.
Transactions by insiders
Recent insider trading involved Allen Dick, Director, that happened on May 30 ’24 when 5000.0 shares were sold. Director, Allen Dick completed a deal on Nov 27 ’23 to buy 5000.0 shares. Meanwhile, EVP & CHIEF FINANCIAL OFFICER Vosseller Leigh bought 6200.0 shares on Nov 08 ’23.
